Literature DB >> 20628826

Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.

Angela Castela1, Raquel Soares, Fátima Rocha, Pedro Vendeira, Ronald Virag, Carla Costa.   

Abstract

Erectile dysfunction (ED) is a common problem in aged men; however, the molecular events involved in aging ED remain unclear. To better characterize the effects of aging in the penis, we evaluated cavernosal tissue remodeling capability and the downstream activation of the intracellular signaling mediator mitogen-activated protein p42/44 kinase (p42/44 MAPK). We used male Wistar rats, which were divided in groups of 2, 6, 12, 18, and 24 months old. Penile tissues were harvested and processed for protein isolation and immunohistochemical analysis. Cavernosal viability was assessed by TUNEL assay, and proliferation was analyzed by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Immunolocalization of the activated form of p42/44 MAPK was evaluated by immunofluorescence, and changes in its phosphorylation status were quantified by western blotting. p42/44 phosphorylation profile was also assessed in situ in human young and elderly cavernosal samples. With the advancement of age, experimental cavernosal tissue remodeling was affected by an age-dependent unbalance between the rate of apoptosis and proliferation, in all erectile components. Moreover, this turnover alteration was accompanied by significant modifications in the activation profile of the downstream effector p42/44 MAPK. In the youngest corporeal samples, p42/44 was mostly activated at perivascular sites, potentially mediating cell survival/proliferation. However, in elderly experimental erectile tissue, p42/44 phosphorylation shifted to trabecular fibroblasts, indicating a potential role in extracellular matrix (ECM) production. More importantly, the same differential pattern of p42/44 activation was observed in human young and aged cavernosal fragments, suggesting a distinct function of this protein with aging. We provided evidence for the first time that with the advancement of age, there is a differential activation of p42/44 MAPK in cavernosal tissue, which may promote ECM expansion and fibrosis, therefore compromising erectile function in the elderly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628826      PMCID: PMC3127464          DOI: 10.1007/s11357-010-9167-3

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  28 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats.

Authors:  M E Bakircioglu; K D Sievert; L Nunes; A Lau; C S Lin; T F Lue
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

Review 3.  Smooth muscle pathology and erectile dysfunction.

Authors:  E Wespes
Journal:  Int J Impot Res       Date:  2002-02       Impact factor: 2.896

4.  Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities.

Authors:  Shizuo Ikeyama; Gertrude Kokkonen; Sonsoles Shack; Xian-Tao Wang; Nikki J Holbrook
Journal:  FASEB J       Date:  2001-11-14       Impact factor: 5.191

Review 5.  Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism.

Authors:  R B Moreland
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

Review 6.  The ageing male and erectile dysfunction.

Authors:  F Montorsi; A Briganti; A Salonia; F Deho'; G Zanni; A Cestari; G Guazzoni; P Rigatti; C Stief
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

Review 7.  Vasculogenic erectile dysfunction: newer therapeutic strategies.

Authors:  Mike B Siroky; Kazem M Azadzoi
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

8.  Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells.

Authors:  Mahadevan Rajasekaran; Armen Kasyan; Warren Allilain; Manoj Monga
Journal:  J Androl       Date:  2003 Jan-Feb

9.  Loss of anti-apoptotic genes in aging rat crura.

Authors:  Masaki Yamanaka; Masato Shirai; Hiroaki Shiina; Masafumi Shirai; Yuichiro Tanaka; Makoto Fujime; Aakihiko Okuyama; Rajvir Dahiya
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

10.  MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum.

Authors:  F Sommer; T Klotz; D Steinritz; A Schmidt; K Addicks; U Engelmann; W Bloch
Journal:  Int J Impot Res       Date:  2002-08       Impact factor: 2.896

View more
  2 in total

1.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

Review 2.  Reversion of penile fibrosis: Current information and a new horizon.

Authors:  Ahmed I El-Sakka
Journal:  Arab J Urol       Date:  2011-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.